Phreesia (NYSE:PHR) Given “Sector Perform” Rating at Royal Bank of Canada

Royal Bank of Canada restated their sector perform rating on shares of Phreesia (NYSE:PHR) in a research report released on Friday, Benzinga reports. The brokerage currently has a $23.00 target price on the stock.

Several other equities analysts also recently weighed in on PHR. JMP Securities reaffirmed a market outperform rating and issued a $30.00 price objective on shares of Phreesia in a research note on Thursday, September 5th. Stephens restated an overweight rating and issued a $28.00 price target on shares of Phreesia in a research report on Friday, May 31st. Robert W. Baird boosted their price objective on shares of Phreesia from $31.00 to $34.00 and gave the stock an outperform rating in a research report on Friday, September 6th. Canaccord Genuity Group reissued a buy rating and issued a $34.00 price objective on shares of Phreesia in a research note on Thursday, September 5th. Finally, KeyCorp cut their target price on shares of Phreesia from $27.00 to $25.00 and set an overweight rating for the company in a research report on Thursday, July 11th. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, Phreesia presently has a consensus rating of Moderate Buy and a consensus target price of $29.42.

Phreesia Price Performance

Phreesia stock opened at $22.79 on Friday. The company has a market cap of $1.32 billion, a P/E ratio of -10.50 and a beta of 0.93. Phreesia has a one year low of $12.05 and a one year high of $29.16. The business has a fifty day moving average of $24.01 and a two-hundred day moving average of $22.63. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.77 and a current ratio of 1.77.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Wednesday, September 4th. The company reported ($0.31) EPS for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.06. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. The firm had revenue of $102.12 million for the quarter, compared to the consensus estimate of $101.76 million. As a group, analysts predict that Phreesia will post -1.23 earnings per share for the current fiscal year.

Insider Transactions at Phreesia

In related news, General Counsel Allison C. Hoffman sold 14,110 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $26.03, for a total transaction of $367,283.30. Following the transaction, the general counsel now owns 121,003 shares of the company’s stock, valued at $3,149,708.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, General Counsel Allison C. Hoffman sold 14,110 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $26.03, for a total value of $367,283.30. Following the completion of the transaction, the general counsel now directly owns 121,003 shares in the company, valued at $3,149,708.09. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Allison C. Hoffman sold 2,622 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $60,961.50. Following the completion of the sale, the general counsel now directly owns 123,075 shares in the company, valued at $2,861,493.75. The disclosure for this sale can be found here. Insiders sold a total of 46,203 shares of company stock worth $1,129,699 over the last ninety days. 5.80% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Phreesia

Several institutional investors and hedge funds have recently bought and sold shares of PHR. nVerses Capital LLC raised its stake in Phreesia by 76.5% during the second quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock worth $64,000 after purchasing an additional 1,300 shares during the period. EntryPoint Capital LLC acquired a new position in Phreesia in the first quarter valued at $169,000. Quadrature Capital Ltd acquired a new position in Phreesia in the first quarter valued at $202,000. Lombard Odier Asset Management USA Corp purchased a new stake in Phreesia during the second quarter valued at about $202,000. Finally, Point72 DIFC Ltd purchased a new stake in Phreesia during the second quarter valued at about $209,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.